De-implementation of URInary catheters in Neurosurgical patients during the operation and on the ward

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON20496

Enrollment

2000

Registered

2021-09-30

Start date

2020-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Anterior skull base operations (transsphenoidal resection of pituitary gland tumours) and 2. Spinal fusion operations (spondylodesis)

Interventions

In this study, there will be no interventions in the consisting situation in order to study the effect of that intervention. Multiple de-implementation strategies will be used to decrease the number o

Eligibility

Inclusion criteria

Inclusion criteria: To be included in the DURIN study the following conditions must be met for healthcare professionals: - Age = 18 years; - Must work as a neurosurgeon, neurosurgical resident, operation assistant, recovery nurse or neurosurgical ward nurse, - For the satisfaction survey: informed consent is obtained, - For the focus groups: informed consent is obtained. To be included in the DURIN study the following conditions must be met for patients: - Age = 18 years, - Underwent transsphenoical pituitary gland tumour surgery or spinal fusion surgery (spondylodesis), - For the satisfaction survey: informed consent is obtained.

Exclusion criteria

Exclusion criteria: A potential participant (healthcare professional) who meets any of the following criteria will be excluded from participation: - For the satisfaction survey: no informed consent is obtained, - For the focus groups: no informed consent is obtained. A potential participant (patient) who meets any of the following criteria will be excluded from participation: - Operation time > 4 hours; - Preexisting bladder complications for which an IDUC is used pre-operatively; - Peri- or postoperative neurological deficit (e.g. paresis); - Preexisting psychological problems; - Unable to understand and/or execute instructions from healthcare professionals; - Not speaking fluent in Dutch - For the satisfaction survey: no informed consent is obtained.

Design outcomes

Primary

Measure	Time frame
The primary study parameter will be the number of IDUCS that are placed during and/or after transsphenoidal pituitary gland tumour surgery and spinal fusion surgery (spondylodesis). Data corresponding to the IDUC placement (e.g. date of insertion, time of placement, location of insertion, reason of insertion and which discipline inserted the IDUC) will also be collected. Data will be obtained from the medical charts of patients who underwent these types of surgery from December 2018 until December 2022.	—

Measure

Time frame

The primary study parameter will be the number of IDUCS that are placed during and/or after transsphenoidal pituitary gland tumour surgery and spinal fusion surgery (spondylodesis). Data corresponding to the IDUC placement (e.g. date of insertion, time of placement, location of insertion, reason of insertion and which discipline inserted the IDUC) will also be collected. Data will be obtained from the medical charts of patients who underwent these types of surgery from December 2018 until December 2022.

—

Secondary

Measure	Time frame
Secondary parameters will be measured by conducting medical charts research, satisfaction surveys and focus groups. Medical chart research: - Incidence of intermitted urinary catheterization, including: date of insertion, time of placement, location of insertion, reason of insertion and which discipline inserted the catheter, - Incidence and volume of urinary retention bladders, including: date of urinary retention and where the urinary retention was noticed, - Incidence of urinary tract infections. The diagnosis of a symptomatic urinary tract infection, with or without an IDUC, is the detection of bacteria and leukocytes in the presence of clinical symptoms. This definition is chosen since asymptomatic urinary tract infections can be expected when testing urine from an IDUC without the presence of symptoms and do not require antibiotic therapy. Clinical symptoms include painful and frequent urination, fever, flank pain and general malaise . The pathogen and leukocytes are detected and identified by using midstream urine for a urine sediment. The sediment must contain >103 cfu/mL bacteria and >5 leukocytes. - Operation duration, - Duration of stay in recovery room, - Date of operation, - Age, - Sex, - Length of hospital stay Satisfaction surveys: - Healthcare professionals’ satisfaction with IDUC policy, - Patients’ satisfaction with IDUC policy. Healthcare professionals will receive an online survey during both the baseline measurement as well as the after measurement period. Patients will receive a hardcopy survey if they are admitted to the hospital. Focus groups: - Healthcare professionals’ satisfaction with IDUC policy, - Perceptions on IDUC use - Perceptions on alternatives for IDUCS Per hospital, the focus groups will take place twice during the study: once during the baseline measurement and once during the after measurement.	—

Measure

Time frame

Secondary parameters will be measured by conducting medical charts research, satisfaction surveys and focus groups. Medical chart research: - Incidence of intermitted urinary catheterization, including: date of insertion, time of placement, location of insertion, reason of insertion and which discipline inserted the catheter, - Incidence and volume of urinary retention bladders, including: date of urinary retention and where the urinary retention was noticed, - Incidence of urinary tract infections. The diagnosis of a symptomatic urinary tract infection, with or without an IDUC, is the detection of bacteria and leukocytes in the presence of clinical symptoms. This definition is chosen since asymptomatic urinary tract infections can be expected when testing urine from an IDUC without the presence of symptoms and do not require antibiotic therapy. Clinical symptoms include painful and frequent urination, fever, flank pain and general malaise . The pathogen and leukocytes are detected and identified by using midstream urine for a urine sediment. The sediment must contain >103 cfu/mL bacteria and >5 leukocytes. - Operation duration, - Duration of stay in recovery room, - Date of operation, - Age, - Sex, - Length of hospital stay Satisfaction surveys: - Healthcare professionals’ satisfaction with IDUC policy, - Patients’ satisfaction with IDUC policy. Healthcare professionals will receive an online survey during both the baseline measurement as well as the after measurement period. Patients will receive a hardcopy survey if they are admitted to the hospital. Focus groups: - Healthcare professionals’ satisfaction with IDUC policy, - Perceptions on IDUC use - Perceptions on alternatives for IDUCS Per hospital, the focus groups will take place twice during the study: once during the baseline measurement and once during the after measurement.

—

Contacts

Public ContactJeanne-Marie Nollen

Leids Universitair Medisch Centrum

J.M.Nollen@lumc.nl+31618174099

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)